Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 30,337 | 29,733 | 21,359 | 89,012 | 21,214 |
| Cost of Goods | 5,928 | 5,725 | 5,209 | 3,436 | 6,318 |
| Gross Profit | 24,409 | 24,008 | 16,150 | 85,576 | 14,896 |
| Operating Expenses | 82,973 | 77,144 | 79,637 | 73,885 | 66,582 |
| Operating Income | -57,636 | -52,411 | -63,278 | 12,127 | -51,368 |
| Interest Expense | 12,276 | 13,169 | 10,993 | 8,570 | 9,417 |
| Other Income | 2,763 | 3,639 | 3,400 | 2,526 | 9,599 |
| Pre-tax Income | -67,149 | -61,941 | -70,871 | 6,083 | -51,186 |
| Net Income Continuous | -67,149 | -61,941 | -70,871 | 6,083 | -51,186 |
| Net Income | $-67,149 | $-61,941 | $-70,871 | $6,083 | $-51,186 |
| EPS Basic Total Ops | -1.30 | -1.20 | -1.38 | 0.12 | -0.99 |
| EPS Basic Continuous Ops | -1.30 | -1.20 | -1.38 | 0.12 | -0.98 |
| EPS Diluted Total Ops | -1.30 | -1.20 | -1.38 | 0.12 | -0.99 |
| EPS Diluted Continuous Ops | -1.30 | -1.20 | -1.38 | 0.12 | -0.98 |
| EPS Diluted Before Non-Recurring Items | -1.30 | -1.20 | -1.38 | 0.12 | -1.01 |
| EBITDA(a) | $-53,767 | $-46,098 | $-60,729 | $15,011 | $-47,345 |